Biovica announced that the company has entered into a commercial agreement with a leading healthcare provider that operates more than 30 hospital laboratories, primarily located in Arizona. The agreement will ensure access to DiviTum TKa for patients across the partners extensive network covering the southwest region of the United States. This agreement marks Biovica's first commercial hospital (client bill) agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 SEK | +2.04% | +5.77% | +6.59% |
06-28 | Biovica to Provide Biomarker Testing for US Biopharmaceutical Company | MT |
06-28 | Biovica International Signs New Agreement Supporting Pharma Development | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.59% | 21.81M | |
-42.89% | 7.8B | |
+6.77% | 3.53B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
-26.12% | 533M | |
+1.19% | 297M |
- Stock Market
- Equities
- BIOVIC B Stock
- News Biovica International AB
- Biovica Signs US Agreement with Leading Healthcare Provider in Arizona